Shape-memory balloon offering simultaneous thermo/chemotherapies to improve anti-osteosarcoma efficacy.


Journal

Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571

Informations de publication

Date de publication:
12 Oct 2021
Historique:
pubmed: 22 9 2021
medline: 15 10 2021
entrez: 21 9 2021
Statut: epublish

Résumé

This paper proposes a shape-memory balloon (SMB) to improve bone cement injection efficiency and postoperative thermo/chemotherapy for bone tumors. The SMB consists of biodegradable poly(ε-caprolactone) (PCL), an anticancer drug (doxorubicin, DOX), and heat-generating magnetic nanoparticles (MNPs). The balloon shape is fabricated in a mold by crosslinking PCL macromonomers with DOX and MNPs. The mechanical properties and shape-transition temperature (approximately 40 °C) of the SMB are modulated by adjusting the molecular weight of PCL and the crosslinking density. This allows safe inflation at the affected site with a 400% expansion rate by simple blow molding. The expanded shape is temporarily memorized at 37 °C, and the computed tomography image shows that the bone cement is successfully injected without extra pressure or leakage. The SMB releases DOX for over 4 weeks, allowing a prolonged effect at the local site. The local dosing is constant as the medication is continuously released, demonstrating an ON-OFF switchable heating/cooling response to alternating magnetic field irradiation.

Identifiants

pubmed: 34546257
doi: 10.1039/d1bm00780g
doi:

Substances chimiques

Drug Carriers 0
Micelles 0
Polyesters 0
Doxorubicin 80168379AG

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6957-6965

Auteurs

Sosuke Ouchi (S)

Research Center for Functional Materials, National Institute for Materials Science (NIMS), Ibaraki 305-0044, Japan. EBARA.Mitsuhiro@nims.go.jp.
Department of Materials Science and Technology, Tokyo University of Science, Tokyo 125-8585, Japan.

Eri Niiyama (E)

Research Center for Functional Materials, National Institute for Materials Science (NIMS), Ibaraki 305-0044, Japan. EBARA.Mitsuhiro@nims.go.jp.
Graduate School of Pure and Applied Sciences, University of Tsukuba, Ibaraki 305-8577, Japan.

Ken Sugo (K)

Research Center for Functional Materials, National Institute for Materials Science (NIMS), Ibaraki 305-0044, Japan. EBARA.Mitsuhiro@nims.go.jp.
Graduate School of Pure and Applied Sciences, University of Tsukuba, Ibaraki 305-8577, Japan.

Koichiro Uto (K)

Research Center for Functional Materials, National Institute for Materials Science (NIMS), Ibaraki 305-0044, Japan. EBARA.Mitsuhiro@nims.go.jp.

Satoshi Takenaka (S)

Department of Orthopaedic Surgery, Osaka International Cancer Institute, Osaka 541-8567, Japan.

Akihiko Kikuchi (A)

Department of Materials Science and Technology, Tokyo University of Science, Tokyo 125-8585, Japan.

Mitsuhiro Ebara (M)

Research Center for Functional Materials, National Institute for Materials Science (NIMS), Ibaraki 305-0044, Japan. EBARA.Mitsuhiro@nims.go.jp.
Department of Materials Science and Technology, Tokyo University of Science, Tokyo 125-8585, Japan.
Graduate School of Pure and Applied Sciences, University of Tsukuba, Ibaraki 305-8577, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH